Loading chat...
OK SB1307
Bill
AI Summary
-
Prohibits prescription drug manufacturers in Oklahoma from making payments to generic drug manufacturers in exchange for agreements to halt or forego production of generic versions of their drugs.
-
Out-of-state prescription drug manufacturers who make such payments are subject to fines by the Board of Pharmacy equal to 90% of total in-state sales of the affected drug during the agreement period.
-
Codifies the prohibition as Section 374 of Title 59 of the Oklahoma Statutes.
-
Becomes effective November 1, 2010.
Legislative Description
Professions and occupations; prohibiting certain agreements by prescription drug manufacturers. Effective date.
Health Care
Last Action
Second Reading referred to Health and Human Services
2/2/2010
Committee Referrals
Health and Human Services2/2/2010
Full Bill Text
No bill text available